Biomarkers in acute respiratory distress syndrome.

Matthieu Jabaudon, Raiko Blondonnet, Lorraine B Ware

Current opinion in critical care 2021 Feb 01

filter terms:

This article provides an overview of protein biomarkers for acute respiratory distress syndrome (ARDS) and their potential use in future clinical trials. The protein biomarkers studied as indices of biological processes involved in the pathogenesis of ARDS may have diagnostic and/or prognostic value. Recently, they also proved useful for identifying ARDS phenotypes and assessing heterogeneity of treatment effect in retrospective analyses of completed clinical trials. This article summarizes the current research on ARDS biomarkers and provides insights into how they should be integrated as prognostic and predictive enrichment tools in future clinical trials. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Citation

Matthieu Jabaudon, Raiko Blondonnet, Lorraine B Ware. Biomarkers in acute respiratory distress syndrome. Current opinion in critical care. 2021 Feb 01;27(1):46-54